Owners, management and financials
CVR: 61094628
Secondary names: AXELLIA PHARMACEUTICALS ApS
Previous names: A/S DUMEX (DUMEX LTD.), DUMEX-ALPHARMA A/S, DUMEX-ALPHARMA ApS
DKK 1,461,516,000
Revenue
Net result: DKK 213,738,000
XELLIA GROUP ApS (100%)
CVR · view owners
Michael Kocher
Board: Søren Hostrup (chair) and 6 members
CVR · view management
Active
Founded 31 March 1959
CVR · view overview
595 employees
CVR · 2018
Director role ended: Carl-Åke Carlsson
CVR · 01/10/2023
View the full event history
XELLIA PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in København S, founded in 1959. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The company was previously named AXELLIA PHARMACEUTICALS ApS and ALPHARMA ApS. The management consists of Michael Kocher. The board consists of Søren Hostrup (chair), Alexander Sebastian Benjamin Sproedt, Eva Blem and Lars Beck Madsen. The company is owned by XELLIA GROUP ApS. The company has 595 employees (2018). In 2025, the company reported revenue of DKK 1,461,516,000 and a net result of DKK 213,738,000 compared with DKK 828,966,000 the year before. Equity in the 2025 report amounted to DKK 404,569,000.
Source: annual report 2025, Danish Business Authority
Xellia Pharmaceuticals ApS has experienced significant financial volatility, with a concerning trend of declining profitability and fluctuating revenues over the past few years. In 2025, revenue decreased to 1.46 billion DKK, accompanied by a profit of 213.7 million DKK, a stark contrast to the previous year's profit of 828.9 million DKK on revenues of 1.6 billion DKK. The company faced substantial losses in 2023 and 2022, indicating ongoing challenges in maintaining profitability and a deteriorating equity position, which fell to 404.6 million DKK in 2025 from over 2 billion DKK in 2021. Despite being a notable player in the pharmaceutical raw materials sector, the significant equity erosion and recent profit fluctuations raise concerns about its financial stability and operational efficiency.
AI-generated summary · Generated 13/06/2026
Selskabets formål er at drive fabrikation af og handel med medicinalvarer til human eller veterinær brug, finkemikalier, kosmetik, forskning og udvikling samt hermed beslægtet virksomhed enten direkte eller ved anbringelse af kapital i selskaber med ligende formål samt at virke som repræsentant eller alliancepartner for danske og udenlandske virksomheder inden for sådanne forretningsområder.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 1.5 mia. | 213.7 mio. | 2.8 mia. | 404.6 mio. | 453 | |
| 202401/01/2024 – 31/12/2024 | 1.6 mia. | 829 mio. | 3.2 mia. | 162.5 mio. | 547 | |
| 202301/01/2023 – 31/12/2023 | 2 mia. | -2.4 mia. | 2.1 mia. | -597.8 mio. | 650 | |
| 202201/01/2022 – 31/12/2022 | 2.2 mia. | -371.5 mio. | 3.5 mia. | 1.8 mia. | 648 | |
| 202101/01/2021 – 31/12/2021 | 1.8 mia. | -503.1 mio. | 3.7 mia. | 2.1 mia. | 640 | |
| 202001/01/2020 – 31/12/2020 | 2 mia. | -115.7 mio. | 4.1 mia. | 2.6 mia. | 624 | |
| 201901/01/2019 – 31/12/2019 | 2.3 mia. | 390.7 mio. | 2.7 mia. | 1.4 mia. | 623 | |
| 201801/01/2018 – 31/12/2018 | 1.9 mia. | -74.9 mio. | 2.4 mia. | 1 mia. | 580 | |
| 201701/01/2017 – 31/12/2017 | 1.9 mia. | 91 mio. | 2.5 mia. | 850.8 mio. | 493 | |
| 201601/01/2016 – 31/12/2016 | 1.5 mia. | 33.8 mio. | 2.4 mia. | 758.8 mio. | 466 | |
| 201501/01/2015 – 31/12/2015 | 1.2 mia. | -74 mio. | 1.7 mia. | 729.2 mio. | 479 |
Compared to 25 companies in Fremstilling af farmaceutiske råvarer
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
5 properties
Upgrade to Pro to see addresses, building data and ownership details
Property report (PDF)
The entire property portfolio in one report: areas, usage, energy labels, flood exposure, planning zone and local plans.
See an example report (PDF)Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationThe CVR number of XELLIA PHARMACEUTICALS ApS is 61094628.
XELLIA PHARMACEUTICALS ApS is owned by XELLIA GROUP ApS.
The management of XELLIA PHARMACEUTICALS ApS consists of Michael Kocher.
The board of XELLIA PHARMACEUTICALS ApS consists of Søren Hostrup, Alexander Sebastian Benjamin Sproedt and Eva Blem, with Søren Hostrup as chair.
In 2025, XELLIA PHARMACEUTICALS ApS reported revenue of DKK 1,461,516,000.
XELLIA PHARMACEUTICALS ApS had 595 employees in 2018 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
Contact info changed: new phone: 32645500 (June 16, 2026).
XELLIA PHARMACEUTICALS ApS has published its annual report for 2025. Revenue came to DKK 1,461,516,000, and the net result was DKK 213,738,000.
As of June 3, 2026, Alexander Sebastian Benjamin Sproedt has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of June 3, 2026, Michael Kocher has left the board of directors of XELLIA PHARMACEUTICALS ApS.
XELLIA PHARMACEUTICALS ApS has published its annual report for 2024. Revenue came to DKK 1,599,382,000, and the net result was DKK 828,966,000.
As of April 30, 2025, Eva Blem has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of April 30, 2025, Bente Schmidt Nielsen has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of September 27, 2024, Michael Uhd has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of September 27, 2024, Thomas Clement Guldager has left the board of directors of XELLIA PHARMACEUTICALS ApS.
XELLIA PHARMACEUTICALS ApS has published its annual report for 2023. Revenue came to DKK 1,986,816,000, and the net result was DKK -2,384,901,000.
As of April 11, 2024, Thomas Clement Guldager has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of April 11, 2024, John Ramsay Stewart has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of October 1, 2023, Michael Kocher has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of October 1, 2023, John Ramsay Stewart has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of October 1, 2023, Carl-Åke Carlsson has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of October 1, 2023, Geelanie Rodriguez Briones has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of October 1, 2023, Michael Kocher is registered as director of XELLIA PHARMACEUTICALS ApS.
As of October 1, 2023, Carl-Åke Carlsson has stepped down as director of XELLIA PHARMACEUTICALS ApS.
XELLIA PHARMACEUTICALS ApS has published its annual report for 2022. Revenue came to DKK 2,245,303,000, and the net result was DKK -371,486,000.
As of February 28, 2023, Gisli Lukas Lundahl has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of February 6, 2023, Geelanie Rodriguez Briones has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of February 6, 2023, Niels Murmann has left the board of directors of XELLIA PHARMACEUTICALS ApS.
XELLIA PHARMACEUTICALS ApS has published its annual report for 2021. Revenue came to DKK 1,792,626,000, and the net result was DKK -503,090,000.
As of March 25, 2022, Lone Thiis has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 25, 2022, Martin Bech has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 25, 2022, Gisli Lukas Lundahl has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 25, 2022, Thomas Schou Hunderup has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 24, 2022, Lone Thiis has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of September 13, 2021, Søren Hostrup has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of September 13, 2021, Mikkel Lyager Olsen has left the board of directors of XELLIA PHARMACEUTICALS ApS.
XELLIA PHARMACEUTICALS ApS has published its annual report for 2020. Revenue came to DKK 2,042,515,000, and the net result was DKK -115,666,000.
As of April 30, 2021, Lone Thiis has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of April 30, 2021, Jakob Christian Andersen has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of April 29, 2021, Lone Thiis has left the board of directors of XELLIA PHARMACEUTICALS ApS.
XELLIA PHARMACEUTICALS ApS has published its annual report for 2019. Revenue came to DKK 2,346,296,000, and the net result was DKK 390,722,000.
XELLIA PHARMACEUTICALS ApS has published its annual report for 2018. Revenue came to DKK 1,890,464,000, and the net result was DKK -74,912,000.
XELLIA PHARMACEUTICALS ApS has published its annual report for 2017. Revenue came to DKK 1,897,063,000, and the net result was DKK 91,002,000.
As of March 22, 2018, Lone Thiis has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 22, 2018, Lars Beck Madsen has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 22, 2018, Thomas Schou Hunderup has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 22, 2018, Jakob Christian Andersen has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 22, 2018, Lennart Bo Fredmark has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 22, 2018, Lars Mosberg has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 22, 2018, Lone Finner has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 21, 2018, Thomas Schou Hunderup has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of January 3, 2018, Niels Murmann has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of January 3, 2018, Mads Bodenhoff has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of December 7, 2017, Lennart Bo Fredmark has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of December 7, 2017, Lone Finner has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of December 7, 2017, Jan Høgh Bergmann has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of December 6, 2017, Lennart Bo Fredmark has left the board of directors of XELLIA PHARMACEUTICALS ApS.
XELLIA PHARMACEUTICALS ApS has published its annual report for 2016. Revenue came to DKK 1,475,168,000, and the net result was DKK 33,769,000.
XELLIA PHARMACEUTICALS ApS has published its annual report for 2015. Revenue came to DKK 1,215,664,000, and the net result was DKK -74,009,000.
As of February 9, 2016, Lars Mosberg has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of February 9, 2016, Susanne Lisby has left the board of directors of XELLIA PHARMACEUTICALS ApS.
XELLIA PHARMACEUTICALS ApS has published its annual report for 2014.
As of September 1, 2014, Mads Bodenhoff has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of September 1, 2014, Kennet Ingvar Lundberg has left the board of directors of XELLIA PHARMACEUTICALS ApS.
XELLIA PHARMACEUTICALS ApS has published its annual report for 2013.
As of March 24, 2014, Jan Høgh Bergmann has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 24, 2014, Susanne Lisby has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 24, 2014, Lennart Bo Fredmark has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 24, 2014, Thomas Schou Hunderup has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 24, 2014, Aage Ole Egholm Larsen has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 24, 2014, Jakob Toft Mossing has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 24, 2014, Frank Jensen has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of July 17, 2013, XELLIA GROUP ApS is registered as an owner of XELLIA PHARMACEUTICALS ApS with an ownership share of 100%.
As of June 10, 2013, Jakob Toft Mossing has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of June 10, 2013, Jakob Toft Mossing has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of June 10, 2013, Michael Graakjær has left the board of directors of XELLIA PHARMACEUTICALS ApS.
XELLIA PHARMACEUTICALS ApS has published its annual report for 2012.
As of July 1, 2011, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of XELLIA PHARMACEUTICALS ApS.
As of July 1, 2011, A/S PSE NR. 4820 has stepped down as auditor of XELLIA PHARMACEUTICALS ApS.
As of April 14, 2010, Jakob Toft Mossing has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of April 14, 2010, Torben Koch has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of April 14, 2010, Gert Ibsen has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of April 14, 2010, Anette Melchior Jensen has left the board of directors of XELLIA PHARMACEUTICALS ApS.
On March 1, 2010, the company changed its name from AXELLIA PHARMACEUTICALS ApS to XELLIA PHARMACEUTICALS ApS.
As of September 10, 2009, Mikkel Lyager Olsen has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of September 10, 2009, Carl-Åke Carlsson has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of July 31, 2009, Kennet Ingvar Lundberg has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of July 31, 2009, Stig Jarle Pettersen has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of February 17, 2009, Torben Jung Laursen has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of December 10, 2008, Mikkel Lyager Olsen has stepped down as director of XELLIA PHARMACEUTICALS ApS.
On June 20, 2008, the company changed its name from ALPHARMA ApS to AXELLIA PHARMACEUTICALS ApS.
As of May 29, 2008, A/S PSE NR. 4820 has been appointed auditor of XELLIA PHARMACEUTICALS ApS.
As of May 29, 2008, A/S PSE 17 NR. 1056 has stepped down as auditor of XELLIA PHARMACEUTICALS ApS.
As of May 8, 2008, Mikkel Lyager Olsen is registered as director of XELLIA PHARMACEUTICALS ApS.
As of April 22, 2008, Stig Jarle Pettersen has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of February 1, 2008, Steen Asferg Rasmussen has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of February 1, 2008, Steen Asferg Rasmussen has stepped down as director of XELLIA PHARMACEUTICALS ApS.
As of November 23, 2006, Torben Koch has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of November 23, 2006, Gert Ibsen has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of November 23, 2006, Frank Jensen has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of November 23, 2006, Anette Melchior Jensen has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of November 23, 2006, Torben Koch has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of November 23, 2006, Hans Ketel Ohm Laursen has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of September 28, 2006, Torben Jung Laursen has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of May 16, 2006, Ingrid Beichmann Wiik has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of February 1, 2006, Steen Asferg Rasmussen is registered as director of XELLIA PHARMACEUTICALS ApS.
As of February 1, 2006, Terje Aarbogh has stepped down as director of XELLIA PHARMACEUTICALS ApS.
As of December 30, 2005, Steen Asferg Rasmussen has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of December 30, 2005, Finn Gjersøe has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of December 30, 2005, Henriette Nielsen has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of December 19, 2005, Finn Gjersøe has stepped down as director of XELLIA PHARMACEUTICALS ApS.
As of December 19, 2005, Lis Else Kirkegaard has stepped down as director of XELLIA PHARMACEUTICALS ApS.
As of December 19, 2005, Svend Andersen has stepped down as director of XELLIA PHARMACEUTICALS ApS.
As of September 12, 2005, Bente Schmidt Nielsen has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of September 12, 2005, Søren Peter Thomsen has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of May 23, 2005, A/S PSE 17 NR. 1056 has been appointed auditor of XELLIA PHARMACEUTICALS ApS.
As of May 23, 2005, Pricewaterhouse Coopers has stepped down as auditor of XELLIA PHARMACEUTICALS ApS.
As of May 23, 2005, Ingrid Beichmann Wiik has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of September 29, 2004, Finn Gjersøe is registered as director of XELLIA PHARMACEUTICALS ApS.
As of September 29, 2004, Svend Andersen is registered as director of XELLIA PHARMACEUTICALS ApS.
As of June 2, 2004, Lise Sylvest Helledi has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of May 19, 2004, Finn Gjersøe has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of May 19, 2004, Henriette Nielsen has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of May 19, 2004, Michael Graakjær has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of May 19, 2004, Hans Ketel Ohm Laursen has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of May 19, 2004, Gerner Vejrup has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of May 19, 2004, Torben Jung Laursen has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 31, 2004, Torben Jung Laursen has stepped down as director of XELLIA PHARMACEUTICALS ApS.
As of May 28, 2003, Søren Peter Thomsen has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of May 28, 2003, Sverre Bjertnes has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of February 1, 2003, Lars Saaby Nielsen has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of November 4, 2002, Lis Else Kirkegaard is registered as director of XELLIA PHARMACEUTICALS ApS.
As of November 4, 2002, Terje Aarbogh is registered as director of XELLIA PHARMACEUTICALS ApS.
As of May 15, 2002, Lars Saaby Nielsen has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of May 15, 2002, Jette Elisabeth Skylark has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of May 15, 2002, Charlotte Hemmingsen has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of May 15, 2002, Thor Kristiansen has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of January 1, 2002, Torben Jung Laursen has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of January 1, 2002, Thor Kristiansen has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of January 1, 2002, Thor Kristiansen has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of January 1, 2002, Torben Jung Laursen is registered as director of XELLIA PHARMACEUTICALS ApS.
As of January 1, 2002, Thor Kristiansen has stepped down as director of XELLIA PHARMACEUTICALS ApS.
On November 28, 2000, the company changed its name from DUMEX-ALPHARMA ApS to ALPHARMA ApS.
As of May 22, 2000, Einar Wilhelm Sissener has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of April 13, 2000, Carl-Åke Carlsson is registered as director of XELLIA PHARMACEUTICALS ApS.
As of April 13, 2000, Ingrid Beichmann Wiik has stepped down as director of XELLIA PHARMACEUTICALS ApS.
On April 13, 2000, the company changed its name from DUMEX-ALPHARMA A/S to DUMEX-ALPHARMA ApS.
As of October 1, 1999, Gerner Vejrup has stepped down as director of XELLIA PHARMACEUTICALS ApS.
As of June 16, 1999, Ole Mulvad has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of May 29, 1998, Jette Elisabeth Skylark has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of May 29, 1998, Jette Elisabeth Skylark has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of May 29, 1998, Lise Sylvest Helledi has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of May 29, 1998, Sverre Bjertnes has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of May 29, 1998, Sverre Bjertnes has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of May 29, 1998, Jette Elisabeth Skylark has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of May 29, 1998, Sverre Bjertnes has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of May 21, 1997, Jeffrey Edward Smith has left the board of directors of XELLIA PHARMACEUTICALS ApS.
On January 13, 1996, the company changed its name from A/S DUMEX (DUMEX LTD.) to DUMEX-ALPHARMA A/S.
As of August 1, 1995, Torben Koch has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of August 1, 1995, Torben Koch has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of August 1, 1995, Torben Koch has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of July 31, 1995, Hans Christian Hansen has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of May 31, 1995, Jacob Kortleven Holm has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of May 29, 1995, Niels Lykke Graugaard has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of May 29, 1995, Otto Feierskov Andreasen has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of May 29, 1995, Ingrid Beichmann Wiik is registered as director of XELLIA PHARMACEUTICALS ApS.
As of February 1, 1995, Gerner Vejrup has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of February 1, 1995, Thor Kristiansen has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of February 1, 1995, Gerner Vejrup is registered as director of XELLIA PHARMACEUTICALS ApS.
As of February 1, 1995, Thor Kristiansen is registered as director of XELLIA PHARMACEUTICALS ApS.
As of February 1, 1995, Niels Lykke Graugaard has stepped down as director of XELLIA PHARMACEUTICALS ApS.
As of December 14, 1994, Niels Søby has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of December 14, 1994, Isadore Roy Cohen has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of December 14, 1994, Jeffrey Edward Smith has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of May 19, 1994, Hans Christian Hansen has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of May 19, 1994, Astrid Spillum has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of May 19, 1994, Elsebeth Heldorf Knudsen has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of May 19, 1994, Gitte Lisbeth Kofod has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of September 30, 1993, Oscar William Kaalstad has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of November 11, 1991, William P Altman has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of November 11, 1991, Ricardo Pedro Storm has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of April 17, 1991, Jack van Hulst has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of November 15, 1990, Flemming Riber Larsen has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of October 2, 1990, Hans Bruun Ringsing has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of October 2, 1990, Jørgen Worning has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of October 2, 1990, Elsebeth Heldorf Knudsen has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of October 2, 1990, Jette Elisabeth Skylark has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of October 2, 1990, Jørgen Worning has stepped down as adm. dir. of XELLIA PHARMACEUTICALS ApS.
As of July 21, 1989, Roald Jøtun has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of April 28, 1989, Per Rønsted has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of April 28, 1989, Charles Arthur Baker has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of December 14, 1988, Preben Sigvard Franch Schrøder has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of April 27, 1988, Flemming Bogø Jensen has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of December 21, 1987, Johan Jesper Laier has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of December 21, 1987, Tim Niss Corell has left the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 31, 1959, Pricewaterhouse Coopers has been appointed auditor of XELLIA PHARMACEUTICALS ApS.
As of March 31, 1959, Niels Lykke Graugaard has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 31, 1959, Niels Søby has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 31, 1959, Per Rønsted has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 31, 1959, Hans Christian Hansen has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 31, 1959, Hans Christian Hansen has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 31, 1959, Jacob Kortleven Holm has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 31, 1959, Johan Jesper Laier has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 31, 1959, Hans Bruun Ringsing has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 31, 1959, Aage Ole Egholm Larsen has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 31, 1959, Einar Wilhelm Sissener has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 31, 1959, Otto Feierskov Andreasen has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 31, 1959, Astrid Spillum has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 31, 1959, Flemming Bogø Jensen has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 31, 1959, Jørgen Worning has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 31, 1959, Tim Niss Corell has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 31, 1959, Elsebeth Heldorf Knudsen has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 31, 1959, Elsebeth Heldorf Knudsen has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 31, 1959, Ole Mulvad has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 31, 1959, Flemming Riber Larsen has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 31, 1959, Jette Elisabeth Skylark has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 31, 1959, Preben Sigvard Franch Schrøder has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 31, 1959, Gitte Lisbeth Kofod has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 31, 1959, Charlotte Hemmingsen has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 31, 1959, Oscar William Kaalstad has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 31, 1959, Roald Jøtun has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 31, 1959, Isadore Roy Cohen has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 31, 1959, Charles Arthur Baker has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 31, 1959, William P Altman has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 31, 1959, Jack van Hulst has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 31, 1959, Ricardo Pedro Storm has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 31, 1959, Jeffrey Edward Smith has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 31, 1959, Jeffrey Edward Smith has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of March 31, 1959, Niels Lykke Graugaard is registered as director of XELLIA PHARMACEUTICALS ApS.
As of March 31, 1959, Jørgen Worning is registered as adm. dir. of XELLIA PHARMACEUTICALS ApS.
XELLIA PHARMACEUTICALS ApS was founded on March 31, 1959.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at drive forretning med digital markedsføring og strategi samt enhver i forbindelse hermed stående virksomhed.
Companies in the same industry and area
CVR 45239128
CVR 35442723
CVR 35435212
CVR 39014149
CVR 41912367
